Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort
Permanent lenke
https://hdl.handle.net/10037/21814Dato
2021-03-12Type
Journal articleTidsskriftartikkel
Peer reviewed
Forfatter
Arnstad, Ellen Dalen; Glerup, Mia; Rypdal, Veronika Gjertsen; Peltoniemi, Suvi; Fasth, Anders; Nielsen, Susan; Zak, Marek; Aalto, Kristiina; Berntson, Lillemor; Nordal, Ellen Berit; Herlin, Troels; Romundstad, Pål Richard; Rygg, MariteSammendrag
Background: To study fatigue in young adults with juvenile idiopathic arthritis (JIA) 18 years after disease onset,
and to compare with controls.
Methods: Consecutive children with onset of JIA between 1997 and 2000, from geographically defined areas of
Norway, Sweden, Denmark and Finland were followed for 18 years in a close to population-based prospective cohort study. Clinical features, demographic and patient-reported data were collected. Inclusion criteria in the present study were a baseline visit 6 months after disease onset, followed by an 18-year follow-up with available self-reported fatigue score (Fatigue Severity Scale (FSS), 1–7). Severe fatigue was defined as FSS ≥4. For comparison,
Norwegian age and sex matched controls were used.
Results: Among 377 young adults with JIA, 26% reported severe fatigue, compared to 12% among controls. We
found higher burden of fatigue among participants with sleep problems, pain, poor health, reduced participation in
school/work, physical disability, active disease, or use of disease-modifying anti-rheumatic drugs (DMARDs)/
biologics/systemic steroids. In contrast, participants without these challenges, had fatigue scores similar to controls. Active disease assessed at all three time points (baseline, 8-year and 18-year follow-up) was associated with higher mean fatigue score and higher percentage of severe fatigue compared to disease courses characterized by periods of inactive disease. Predictors of fatigue at the 18-year follow-up were female sex and diagnostic delay of ≥6 months at baseline, and also pain, self-reported poor health, active disease, and previous/ongoing use of DMARDs/
biologics at 8 years.
Forlag
BMCSitering
Arnstad, Glerup, Rypdal, Peltoniemi, Fasth, Nielsen, Zak, Aalto, Berntson, Nordal, Herlin, Romundstad, Rygg. Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort. Pediatric Rheumatology. 2021;19Metadata
Vis full innførselSamlinger
Copyright 2021 The Author(s)